Additionally, sphingomyelin synthase 2 overexpressed in BC acts as a key regulator influencing sphingomyelin (SM) homeostasis and activates TGF-β/Smad signaling pathway to initiate EMT by enhancing TGF-β1 activity level thereby promoting invasion and metastasis of BC cells 93. Here, SGMS2 is linked to breast cancer.